Evidence map›Paper›PMID 42884056›Full record

Trial reportInternational journal of molecular sciences2026

A Randomized Clinical Trial of a Standardized Pumpkin-Seed-Derived Peptide Extract: Body Composition Outcomes and Exploratory Analysis by Baseline Adiposity in Overweight Adults.

Yu-Cheng Lin, Wan-Yu Chung, Yen-Nung Lin, Pang-Kuei Hsu

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu-Cheng LinGraduate Institute of Food Science and Technology, National Taiwan University, Taipei 10617, Taiwan.ORCID 0009-0003-8695-3311
Wan-Yu ChungResearch and Development Department, Greenyn Biotechnology Co., Ltd., Taichung City 40768, Taiwan.ORCID 0009-0008-7346-5155
Yen-Nung LinDepartment of Physical Medicine and Rehabilitation, Wan-Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.ORCID 0000-0002-7350-503X
Pang-Kuei HsuResearch and Development Department, Greenyn Biotechnology Co., Ltd., Taichung City 40768, Taiwan.

Funding

Greenyn Biotechnology Co., Ltd. No specific grant number assigned.
6 · The paper itself

Abstract

This 12-week, randomized, double-blind, placebo-controlled trial enrolled 50 overweight adults who received either a standardized pumpkin-seed-derived preparation (IRK-19

Indexed as

AdiposityBody CompositionCucurbitaOverweightPeptidesPlant ExtractsSeedsAdultBody Mass IndexDouble-Blind MethodFemaleHumansMaleMiddle AgedPeptidesPlant Extractsbaseline adipositybioactive peptidesbody compositiondual-energy X-ray absorptiometryoverweight adultspumpkin seed peptidestreatment response heterogeneity

Identifiers

PMID42884056
PMCPMC13665551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.